H-1B sponsorMAFEIN 04-3039129Updated Jul 2026
Vertex Pharmaceuticals Incorporated
US H-1B Labor Condition Application activity for Vertex Pharmaceuticals Incorporated. Filed 912 disclosures between FY2010 and FY2026 from worksites with a MA headquarters indicator.
Total filings
57
Outside top-N · FY2026
Certified
94.7%
unconditional · FY2026
Withdrawn
0.0%
withdrawn rate · FY2026
Denied
0.0%
rejection rate · FY2026
H-1B outcome breakdown
Share of Vertex Pharmaceuticals Incorporated’s LCAs by DOL case status, all fiscal years. Use the year filter above for a single-year breakdown.
| Outcome | Share |
|---|---|
| Certified | 91.3% |
| Cert-withdrawn | 4.7% |
| Withdrawn | 3.3% |
| Denied | 0.7% |
Certified91.3%
Cert-withdrawn4.7%
Withdrawn3.3%
Denied0.7%
Top occupations sponsored
SOC codes filed most by Vertex Pharmaceuticals Incorporated across all fiscal years. Click any row to open the national salary guide.
| # | SOC | Title | Filings |
|---|---|---|---|
| 1 | 15-2041 | Statisticians | 132 |
| 2 | 15-1252 | Software Developers | 80 |
| 3 | 19-1042 | Medical Scientists, Except Epidemiologists | 74 |
| 4 | 19-2031 | Chemists | 69 |
| 5 | 17-2112 | Industrial Engineers | 45 |
| 6 | 19-1021 | Biochemists and Biophysicists | 34 |
| 7 | 15-1299 | Computer Occupations, All Other | 33 |
| 8 | 15-2051 | Data Scientists | 32 |
| 9 | 19-1029 | Biological Scientists, All Other | 29 |
| 10 | 13-1041 | Compliance Officers | 17 |
Statisticians
132
Software Developers
80
Medical Scientists, Except Epidemiologists
74
Chemists
69
Industrial Engineers
45
Biochemists and Biophysicists
34
Computer Occupations, All Other
33
Data Scientists
32
Biological Scientists, All Other
29
Compliance Officers
17
H-1B filings by fiscal year
Year-over-year H-1B filing volume — a hiring-demand signal, not headcount.
| Year | Filings |
|---|---|
| FY2010 | 33 |
| FY2011 | 26 |
| FY2012 | 29 |
| FY2013 | 31 |
| FY2014 | 73 |
| FY2015 | 29 |
| FY2016 | 32 |
| FY2017 | 59 |
| FY2018 | 50 |
| FY2019 | 53 |
| FY2020 | 8 |
| FY2021 | 20 |
| FY2022 | 32 |
| FY2023 | 39 |
| FY2024 | 150 |
| FY2025 | 191 |
| FY2026 | 57 |
| Period | Value |
|---|---|
| FY2010 | 33 |
| FY2011 | 26 |
| FY2012 | 29 |
| FY2013 | 31 |
| FY2014 | 73 |
| FY2015 | 29 |
| FY2016 | 32 |
| FY2017 | 59 |
| FY2018 | 50 |
| FY2019 | 53 |
| FY2020 | 8 |
| FY2021 | 20 |
| FY2022 | 32 |
| FY2023 | 39 |
| FY2024 | 150 |
| FY2025 | 191 |
| FY2026 | 57 |
Compare Vertex Pharmaceuticals Incorporated with another sponsor
Side-by-side view of KPIs, outcomes, top breakdowns and yearly trend.
Explore by rank
Pre-built leaderboards for the most-asked questions.
Understand the data
Definitions and methodology behind these H-1B figures.